Results 131 to 140 of about 191,054 (269)

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

open access: yesHepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo   +19 more
wiley   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai   +4 more
wiley   +1 more source

Mid‐term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support

open access: yesESC Heart Failure, EarlyView.
Abstract Background Patients with end‐stage heart failure and chronic kidney disease requiring dual‐organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi‐organ failure.
Smruti Desai   +12 more
wiley   +1 more source

Right ventricle to pulmonary artery coupling as a prognostic factor in tricuspid regurgitation: A systematic review

open access: yesESC Heart Failure, EarlyView.
The TAPSE/SPAP ratio is associated with worse prognosis in patients with significant tricuspid regurgitation and could indicate at‐risk patients. The exact cutoff value for RV‐PA uncoupling remains difficult to define and in available studies ranged from 0.26 to 0.49 mm/mmHg.
Adam Piasecki   +5 more
wiley   +1 more source

Predicting acute decompensated heart failure using circadian markers from heart rate time series

open access: yesESC Heart Failure, EarlyView.
Circadian metrics—amplitude, mesor, and acrophase—derived from a wrist‐worn heart rate monitor can predict acute decompensated heart failure (ADHF) up to 21 days before onset. In 65 post‐ADHF patients, an LSTM model achieved 74% sensitivity, and 73% specificity trained on 21‐day sequences. These findings support circadian rhythm analysis as a promising
Valerie A. A. van Es   +9 more
wiley   +1 more source

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

open access: yesESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra   +25 more
wiley   +1 more source

First evaluation of a novel pulsatile LVAD: Feasibility and haemodynamic impact in acute heart failure

open access: yesESC Heart Failure, EarlyView.
The pulsatile ventricular assist platform (pVAP) was connected to a membrane pump in six large swine models. The system, driven by a conventional intra‐aortic balloon pump console (IABP), was utilized to drain left atrial blood during systole and to eject the collected blood back into the ascending aorta during diastole.
Sara Knigge   +11 more
wiley   +1 more source

Four decades of heart–lung transplantation: Milestones and outcomes in advanced cardiorespiratory failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart–lung transplantation (HLTx) remains a life‐saving intervention for patients with end‐stage cardiopulmonary failure. We retrospectively analysed long‐term HLTx outcomes at our centre to assess survival trends and evaluate the impact of evolving immunosuppressive, surgical and perioperative strategies.
L. Lily Rosenthal   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy